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A B S T R A C T   
Background: In early 2020, COVID-19 massively hit Italy, earlier and harder than any other European country. This 
caused a series of strict containment measures, aimed at blocking the spread of the pandemic. Healthcare delivery 
was also affected when resources were diverted towards care of COVID-19 patients, including intensive care wards. 
Aim of the study: The aim is assessing the impact of COVID-19 on cardiac imaging in Italy, compare to the Rest of 
Europe (RoE) and the World (RoW). 
Methods: A global survey was conducted in May–June 2020 worldwide, through a questionnaire distributed 
online. The survey covered three periods: March and April 2020, and March 2019. Data from 52 Italian centres, a 
subset of the 909 participating centres from 108 countries, were analyzed. 
Results: In Italy, volumes decreased by 67% in March 2020, compared to March 2019, as opposed to a signifi-
cantly lower decrease (p < 0.001) in RoE and RoW (41% and 40%, respectively). A further decrease from March 
2020 to April 2020 summed up to 76% for the North, 77% for the Centre and 86% for the South. When compared 
to the RoE and RoW, this further decrease from March 2020 to April 2020 in Italy was significantly less (p =
0.005), most likely reflecting the earlier effects of the containment measures in Italy, taken earlier than anywhere 
else in the West. 
Conclusions: The COVID-19 pandemic massively hit Italy and caused a disruption of healthcare services, including 
cardiac imaging studies. This raises concern about the medium- and long-term consequences for the high number 
of patients who were denied timely diagnoses and the subsequent lifesaving therapies and procedures.  
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1. Introduction 
The coronavirus disease 2019 (COVID-19) pandemic caused by the 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread 
severely in Italy in early 2020, and particularly in its northern regions. 
The first two cases, both tourists from China, were reported at the end of 
January and a confirmed first death noted at the end of February. The 
first medical ethics recommendations regarding triage protocols 
required to be employed were published by the Italian College of 
Anaesthesia, Analgesia, Resuscitation and Intensive Care at the begin-
ning of March [1]. 
Taking an unprecedented decision, and after a series of increasingly 
stricter measures, on March 11 the whole country was decreed in total 
lockdown [2], the first country in Europe and Western world, with free 
circulation not allowed, without written justification, and all activities 
closed, an exception being made for essential services. 
Furthermore, many elective hospital procedures were reduced and/ 
or cancelled at the national level, even if the number of subjects positive 
to COVID-19 was very different in the three macro-areas of the country. 
The same type of decision was taken a few days later by other countries 
in the rest of Europe and worldwide. 
To understand the impact of those restrictions on the provision of 
diagnostic cardiac imaging procedures, the Division of Human Health of 
the International Atomic Energy Agency (IAEA) launched a worldwide 
survey - the IAEA Noninvasive Cardiology Protocols Study of COVID-19 
(INCAPS COVID). For this cross-sectional study, facilities all around the 
world were approached, seeking their voluntary contribution to the 
survey. Initial data on 909 respondents from 108 countries have been 
already published [3]. Out of those 909 centres, 52 were from Italy. 
This aim of this paper is to discuss the variation in volumes of cardiac 
procedures from March 2019 to March and April 2020 in those 52 
centres, analyzing contributions from participants from Italian centres. 
Their results are also compared to the rest of Europe (RoE) and the Rest 
of the World (RoW). 
2. Methods 
A data collection form was designed by an international group of 
IAEA consultants in clinical cardiology and cardiac imaging and 
distributed in May and June 2020 through an online platform, designed 
by the IAEA and named International Research Integration System 
(IRIS) [4]. The questionnaire was conceived to collect general infor-
mation about the healthcare facility; availability and use of personal 
protective equipment (PPE); strategic plans for reopening; changes in 
Fig. 1. The breakdown of the three Italian macro-regions. Northern regions are contoured in green, Central regions in white and Southern and Islands in red. Blue 
dots represents locations of participating centres. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of 
this article.) 
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volume of cardiac procedures performed in March 2020 and April 2020 
as compared to March 2019. 
For Italy, data were aggregated for the whole country and further 
subdivided into three regions identified as Northern Italy; Central Italy; 
and Southern Italy and Islands (Fig. 1). Participating centers were from: 
Ancona (2); Bari; Bergamo; Bologna (3); Bolzano; Brescia (2); Cefalù 
(PA); Chieti; Faenza (RA); Ferrara (2); Firenze; Genova; Mantova; 
Messina; Milano (4); Napoli (3); Novara; Padova; Palermo (2); Pavia; 
Pisa (3); Reggio Emilia (2); Roma (7); Rovigo; Salerno; Siena; Torino (2); 
Trento; Treviso; Veruno (NO). 
Data were also aggregated for the Rest of Europe (RoE) and the Rest 
of the World (RoW). The RoE did not include Italy and likewise RoW did 
not include European countries. European countries were identified 
following the IAEA/United Nations classification [5]. 
Participating centres provided their estimated activity volumes data 
for each modality, as listed in Table 1. To reflect the impact of COVID-19 
on cardiac imaging, those estimates were provided for three time-points, 
starting from March 2019, taken as the pre-COVID control period, then 
March and April 2020. Surveyed cardiac procedures were: Stress elec-
trocardiogram [ECG]; Stress echocardiography [Echo]; Stress single 
photon positron emission computed tomography [SPECT]; Stress posi-
tron emission tomography [PET]; Stress cardiac magnetic resonance 
[CMR]; Coronary Artery Calcium Score [CACS]; Coronary Computed 
Tomography Angiography [CCTA]; Transthoracic echocardiogram 
[TTE]; Transoesophageal echocardiography [TEE]; PET infection; 
Invasive coronary angiography (ICA). 
Based on data published by the Ministry of Health with the support of 
Protezione Civile and Istituto Superiore di Sanità [6], the number of 
COVID-19 tests performed in the three different macro-areas of Italy 
during the surveyed period, 1st March 2020 through 30th April 2020, 
and the percentage of infected subjects, was strikingly different: in the 
North the number of performed test was 1,267,715, with a positivity rate 
of 12.95%, in the Centre performed tests were 419,834 with a positivity 
of 6.39% and in the South tests were 291,668 and positivity was 4.95%. 
2.1. Statistics 
Univariable and multivariable linear regression analyses were per-
formed to evaluate for independent variables associated with procedure 
volume reduction in Italy. Factors analyzed included inpatient vs. 
outpatient practice, academic vs. non-academic practice, facility payer 
mix (private, public, or university), and weighting factors including 
number of hospital beds and baseline procedure volumes. Percentage 
reductions were calculated for each test modality, comparing the pro-
cedure volume from March 2019 to March and April 2020. The per-
centage volume reduction of each procedure type performed in Italy 
over this time period was compared to the reduction seen in RoE and 
RoW. This comparison was performed for each procedure type and 
differences in frequency distributions were statistically compared using 
chi-square and Fisher's exact tests and differences in continuous vari-
ables were compared using the Kruskal-Wallis test. When comparing the 
COVID tests data for the three different areas of Italy, a Z test for two 
binomial distributions was used. 
A p-value < 0.05 is considered statistically significant (two-tailed 
where appropriate). Statistical analysis was conducted using Stata/IC 
16.1 (StataCorp, College Station, TX, USA). 
3. Results 
At worldwide level, responses have been received by 909 centres 
from 108 countries in May and June 2020. To avoid duplicate sub-
missions, when more than one department was involved from the same 
institution, they were requested to merge the different responses in one 
single form. Out of the 909 centres, 52 were from Italy, of which 28 from 
the Northern region, 15 from the Centre and 9 from the South and 
Islands. The percentage of positive subjects was significantly different in 
the 3 macroregions during the surveyed period (North vs Central p <
0.0001; Central vs South p < 0.0001; North vs South p < 0.0001). 
The volume of procedures performed per centre for the whole 
country (Table 1), in March 2019, taken as the control period of the pre- 
pandemic era, did not significantly differ (p = 0.571) from RoE and 
RoW, with median values of 215 for Italy, 260 for RoE and 276 for RoW. 
However, in March 2020 volumes were reduced significantly (p =
0.004) for Italy as compared to RoE and RoW: median values for number 
of procedures/centre were 70, 130 and 150, respectively. In April 2020, 
those volumes of activity were further reduced in Italy as well as in the 
RoE and in the RoW, but differences were no longer statistically sig-
nificant (p = 0.160). The entity of those reductions is also shown in 
Fig. 2. 
Supplementary Table 1 describes Italian and Worldwide variations in 
procedure volumes by facility characteristic, including practice setting 
and academic affiliation. 
In regards to Italy, a breakdown among the three regions shows that 
in March 2020 compared to March 2019 the cardiac procedures 
reduction (Tables 2 and 3) for the North was 65% (median 74 vs 215), 
almost matching the value for the entire nation; for the Centre, the 
reduction was 47% (median 120 vs 223) while it was much higher for 
Southern Italy and Islands (88%, median 20 vs 90), despite a much lower 
incidence of positive COVID cases. These differences, however, fail to 
reach statistical significance (p = 0.114). Of note, the epidemic in 
March–April 2020 hit much harder the North than the Centre and South. 
As regards reduction in cardiac imaging in private, public and uni-
versity centres, no significant difference was found, as shown in Sup-
plementary Table 2. 
If we consider total volumes across the participating centres in Italy, 
cardiac imaging procedures in March 2020 as compared to March 2019 
were reduced to 8138 from 25,579 (Table 2; Fig. 2). In RoE and RoW, a 
similar though smaller reduction was seen (70,759 in March 2020 vs 
117,237 in March 2019 in RoE and 315,535 vs 535,688 in RoW). 
As shown in Table 3, the overall percentage of reduction from March 
2019 to March 2020 was rather homogeneous within Italy, but signifi-
cantly higher for the whole country compared to RoE and RoW (67% vs 
41% vs 40%, respectively; p < 0.001). However, this statistical signifi-
cance in difference is lost when we compare March 2019 with April 
2020 [p = 0.164], reflecting that the further loss of productivity in Italy 
was significantly lower than in RoE and RoW (10% vs 22% vs 20%, 
respectively; p = 0.005) over the period March 2020–April 2020. 
Looking at the surveyed modalities, we see a striking reduction of 
almost all modalities from March 2019 to March 2020 (Table 4 and 
Fig. 3). These reductions were greater, and statistically significant, for 
the country as a whole in comparison to both RoE and RoW, while this 
significance is lost when we compare March 2019 to April 2020, with 
exception made for SPECT, PET and CCTA. Absolute numbers are pre-
sented as raw data in Supplementary Table 3. 
Table 1 
Volumes of cardiac imaging procedures for Italy, RoE and RoW [IQR = Inter-
quartile Range].   
Italy RoE RoW p 
Number of centres 52 201 655  
Number of procedures     
March 2019 25,579 117,237 535,688  
March 2020 8318 70,759 315,535  
April 2020 5763 38,689 199,953  
Procedures/center, 
median [IQR]     

















Bold values indicate changes are statistically significant. 
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Statistical analysis (Table 5) shows that cardiac testing in Italy 
decreased homogeneously without any statistically significant differ-
ence among the three Italian regions across the different procedures in 
both periods. No factors or characteristics considered in our study were 
associated with procedure volume reduction in Italy using a multivari-
able linear regression analysis. Absolute numbers are presented as raw 
data in Supplementary Table 4. 
4. Discussion 
This study is a sub-analysis of data collected from Italy as part of a 
wider worldwide survey [3] about the effects of the COVID-19 pandemic 
on the delivery of diagnostic testing and imaging of CVD. Results show 
that in Italy, during the surveyed period, the overall practice of cardiac 
imaging was heavily affected, down of 67% from March 2019 to March 
2020, and of a further 10% until April 2020, reaching a total of 77% in 
April 2020 as compared to March 2019-. The rapid decrease of cardiac 
procedures are the consequence of the earlier lockdown and the de-
cisions taken by healthcare authorities, stricter than in many other Eu-
ropean countries. This is clearly reflected in Table 3 which shows a 
significantly higher decrease in Italy in March 2020 as compared to RoE 
and RoW where countries have been affected a few weeks later. How-
ever, after other countries took the same actions [7], the differences in 
production become no longer statistically significant in April 2020. This 
is due to a lower volume decrease from March 2020 to April 2020 in 
Italy, as compared to both RoE and RoW, as shown in Table 4. Most 
likely, in March the impact of the very strict containment measures had 
already affected production in Italy while they were still to impact RoE. 
Indeed, the 10% further reduction in cardiac imaging procedures 
registered from March 2020 to April 2020 was significantly smaller in 
Italy than in Europe or worldwide (Table 5; p = 0.005). 
At the level of the three regions as identified in Fig. 1, the decrease of 
cardiac imaging procedures has been homogeneous across the board, 
with the five modalities involving a stressor test more heavily affected 
than the others, possibly in relation to greater risks carried by these tests 
because of aerosolization. Of note, for all modalities, with exception of 
CACS and PET infection, the decrease in volumes was higher, and sta-
tistically significant, than RoE and RoW (Table 5). Therefore, the 
reduction of non-invasive cardiovascular imaging, which has a funda-
mental role in modern healthcare with a robust evidence of its diag-
nostic and prognostic role as shown by numerous studies [8–13], may 











Fig. 2. Volume reduction for Italy, Rest of Europe (RoE), and Rest of World.  
Table 2 
Breakdown of the reduction of cardiac imaging tests among the three Italian 
macro-regions [IQR = Interquartile Range].   
Italy North Centre South p 
Number of 
Centres 
52 15 28 9  
Number of 
procedures      
March 2019 25,579 14,105 8874 2600  
March 2020 8318 5057 2730 531  




[IQR]      















20 [8–38] 0.114 
April 2020 32 
[10–160] 






Reduction in total procedures in percentage.   
Italy Worldwide 
Centre North South p Italy RoE RoW p 
Reduction in total procedures, %         
March 2019 to March 2020 69% 64% 80% 0.467 67% 41% 40% <0.001 
March 2020 to April 2020 7% 13% 6% 0.752 10% 22% 27% 0.005 
March 2019 to April 2020 76% 77% 86% 0.369 77% 63% 67% 0.164 
Bold values indicate changes are statistically significant. 
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The lockdown was decreed for the entire country, implying a 
reduction of diagnostic procedures all over Italy therefore reducing the 
ability to adequately assess patients with known or suspected IHD 
regardless of impact of pandemic. Indeed, the Centre and the South were 
much less affected than the North. However, since the national health-
care system is not uniformly distributed all over the country with areas 
where the access to care facilities and the availability of intensive care is 
limited, it could be assumed that the national lockdown has contributed 
to protect the Centre and South from a possible devastating effect of the 
pandemic. 
During March and April 2020, a dramatic reduction in the number of 
hospitalizations for myocardial infarction and heart failure was seen, 
initially in Italy and later in many other countries [14–16]. A study 
covering Italian CCUs [17], reports a reduction of almost 50% of 
admission rates for acute myocardial infarction. Fatality and complica-
tion rates were comparatively higher in comparison to the previous year, 
with an increase in mortality rate up to 13.7% from 4.1% registered in 
the same period in 2019, possibly due to an increase of 39% of the time 
from symptoms to admission and revascularization [18]. The same study 
has found a 47% reduction of hospitalization for heart failure as 
compared to the same period of 2019, equally involving males and fe-
males. Hospitalization for atrial fibrillation was reduced by 53% and of 
almost 30% for either device failure and pulmonary embolism, which 
could be a result of the excess burden on the health systems, in addition 
to reduced demand and supply of other non-COVID healthcare services. 
A similar trend has been reported for access to emergency departments 
Fig. 3. Volume reduction for Italy, Rest of Europe, and Rest of World by Diagnostic Test in March 2020 an April 2020 as compared to March 2019.  
Table 4 
Reduction by test in Italy, in order of magnitude, as compared to RoE and RoW in the two periods, March 2019 to March 2020 and March 2019 to April 2020.   
March 2019–March 2020, by test March 2019–April 2020, by test 
Italy RoE RoW p Italy RoE RoW p 
Stress PET 93% 37% 12% 0.008 95% 59% 34% 0.009 
Stress CMR 84% 46% 33% 0.031 93% 75% 65% 0.349 
Stress ECG 81% 44% 51% <0.001 93% 85% 79% 0.434 
Stress Echo 80% 50% 54% 0.005 88% 82% 83% 0.552 
TEE 74% 48% 47% 0.022 85% 76% 70% 0.206 
CCTA 70% 49% 37% <0.001 73% 50% 68% 0.002 
CMR 68% 38% 32% 0.000 77% 59% 72% 0.202 
Stress SPECT 66% 39% 46% <0.001 84% 73% 78% 0.006 
PET infection 66% 64% 19% 0.108 71% 71% 44% 0.051 
CACS 66% 63% 46% 0.888 71% 70% 79% 0.534 
TTE 64% 36% 40% <0.001 73% 57% 66% 0.101 
ICA 52% 45% 31% 0.009 61% 59% 48% 0.386 
Bold values indicate changes are statistically significant. 
Table 5 
Reduction by test by region in Italy, in order of magnitude.  
Type of test March 2019–March 2020 Type of test March 2019–April 2020 
Centre North South p Centre North South p 
Stress echo 86% 74% 84% 0.268 Stress echo 94% 83% 86% 0.851 
TEE 85% 63% 94% 0.912 TEE 89% 80% 97% 0.616 
Stress CMR 81% 96% 54% 0.202 Stress CMR 93% 94% 92% 0.925 
CACS 80% 80% 10% 0.472 CACS 70% 100% 30% 0.368 
Stress ECG 78% 83% 83% 0.743 Stress ECG 87% 96% 90% 0.525 
CMR 77% 59% 75% 0.264 CMR 86% 68% 82% 0.020 
PET infection 76% 53% 83% 0.089 PET infection 91% 50% 89% 0.209 
Stress PET 69% 93% 96% 0.844 Stress PET 100% 97% 94% 0.651 
CCTA 68% 71% 81% 0.823 CCTA 73% 72% 77% 0.,840 
TTE 68% 60% 73% 0.448 TTE 69% 74% 85% 0.353 
Stress SPECT 64% 62% 83% 0.889 Stress SPECT 84% 85% 84% 0.123 
ICA 49% 53% 61% 0.777 ICA 63% 60% 77% 0.489  
M. Dondi et al.                                                                                                                                                                                                                                  
International Journal of Cardiology xxx (xxxx) xxx
6
elsewhere [19]. 
A recent Italian study [20] has found a sharp decline by 32% of 
primary PCI rates in ACS during the outbreak of COVID-19, as compared 
to the same period in the previous year. Furthermore, in a paper 
covering only one of the imaging procedures surveyed in this study 
(SPECT MPI), it has been reported that the total number of studies 
decreased by more than two-thirds during the pandemic in comparison 
to the average of the same period of the previous three years, but the 
incidence of positive tests did not [21]. Most likely the same concept 
could be applied to all the other cardiac diagnostic modalities. 
On a wider picture, not only limited to cardiac diseases and based on 
data released by the Italian Institute of Statistics (ISTAT) [22,23], from 
February to November 2020 all over the country there is an excess of 
83,985 deaths as compared to the average in the same period in the 
previous 5 years. While at least 57,647 are confirmed COVID-19 victims, 
i.e. 69% of the excess mortality, a sizeable proportion of the remaining 
26,338 could be considered as indirectly caused by the delays and lim-
itations of healthcare provision induced by the pandemic. In the period 
1st March to 15th April, the increase in mortality was much higher in the 
North of the country, the hardest hit of the three macro-regions with the 
excess mortality up to 168.2% in Lombardy. Notably, in that macro- 
region, an important component ranging from 38% to 56% is not 
attributed to the COVID-19 outbreak [24], according to the COVID 19 
surveillance. That observation refers to all-cause mortality, including 
ischemic heart disease which remains the leading cause of death in 
2019, as reported by the Global Heath Observatory of WHO [25]. 
Results of this study, already confirmed in the worldwide survey [3] 
raise concerns about the reduced utilisation of cardiac imaging testing 
and hence the possible disruption of primary and secondary prevention 
strategies [26,27]. Potentially, it could also impact on the general trend 
of a significant decline in mortality from ischemic heart disease and 
myocardial infarction, as reported by the World Health Organization 
and the United Nations [28,29] over the last 25 years. 
Although we have documented a serious impact on the delivery of 
cardiac imaging, it is well accepted that imaging procedures in general 
are overused, and cardiac imaging is no exception. The need of filtering 
patient access to medical facilities according to new guidelines due to 
the pandemic, might well have reduced inappropriate referrals for car-
diac imaging in general, as already reported for one of the procedures 
surveyed in our paper [30]. 
4.1. Study limitations 
Sites were recruited on a voluntary basis after reaching out for par-
ticipants involved in a range of cardiac procedures, using databases from 
either IAEA and relevant scientific societies, as well as social media and 
personal connections. Therefore, a clear picture of the response rate is 
not possible and is unclear to what extent they are representative of the 
actual situation for each country. As regards the effects of the pandemic, 
it spread at a different pace in other continents, resolving earlier in Asia 
and affecting later the West. Therefore, comparisons with RoW might 
not be entirely correct. As regards Italy, the explanations given to for the 
excess mortality cannot be certified and certainly require more sophis-
ticated statistical analysis, however it's a fact that the COVID-19 
outbreak has halted and reversed a trend towards an overall reduction 
of mortality seen in January and February 2020. 
5. Conclusions 
In March and April 2020, due to the COVID-19 pandemic, the Italian 
National health care system was stressed, and usual delivery of care was 
delayed, as confirmed in this study by the striking reduction of cardiac 
imaging all over the country. As a consequence, a significant number of 
patients did not perform cardiac imaging tests, potentially leading to the 
miss of numerous diagnoses and life-saving procedures. Given the 
fundamental role of cardiac imaging in healthcare programs, there is an 
absolute need to reorganize our departments in order to provide access 
to both infected and non-infected patients without reducing the safety of 
healthcare professionals. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.ijcard.2021.08.044. 
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